-
Thematic Analysis
Aerospace, Defense and Security M&A Deals 2023 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in 2023 in the Aerospace, Defense and Security Sector
-
Sector Analysis
Green Bites – Key Disruptive Forces in Sustainable Nutrition
Disruptive Forces in Sustainable Nutrition Report Overview Advanced developments such as edible insects, food 3D printing, and plant-based proteins are redefining food efficiency and environmental impact in the sustainable nutrition domain. Innovation Curve: Consumer Buy the Full Report to Know More about the Disruptive Forces in Sustainable Nutrition Download a Free Report Sample The ‘Green Bites – Key Disruptive Forces in Sustainable Nutrition’ FutureTech series report categorizes the key innovation areas in sustainable nutrition as emerging, accelerating, and maturing. The...
-
Company Profile
John Bean Technologies Corp – Company Profile
John Bean Technologies Corp (JBT) is a technology solution provider, which offers services to food, beverage, and aviation support industries. Its products include blow-molders, choppers, cutters, and emulsifiers, can seamers and closers, forked AGVs, special application automated guided vehicles (AGVs), towing AGVs, tugger AGVs, unit load AGVs, software, and services, among others. The company’s products find application in automotive, fast-moving consumer goods, food and beverage, healthcare and hospital, packaging, tissue and paper, warehousing, and distribution. The products and services are...
Add to Basket -
Product Insights
Net Present Value Model: Lenabasum
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Lenabasum Drug Details Lenabasum is under...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – lenabasum
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry lenabasum Drug Details Lenabasum is under development for the treatment of systemic lupus erythematosus, diffuse...